These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 24910416

  • 1. Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients.
    Muendlein A, Hubalek M, Geller-Rhomberg S, Gasser K, Winder T, Drexel H, Decker T, Mueller-Holzner E, Chamson M, Marth C, Lang AH.
    Eur J Cancer; 2014 Aug; 50(12):2134-41. PubMed ID: 24910416
    [Abstract] [Full Text] [Related]

  • 2. A common variant of the MACC1 gene is significantly associated with overall survival in colorectal cancer patients.
    Lang AH, Geller-Rhomberg S, Winder T, Stark N, Gasser K, Hartmann B, Kohler B, Grizelj I, Drexel H, Muendlein A.
    BMC Cancer; 2012 Jan 17; 12():20. PubMed ID: 22251819
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Genetic Variation in Metastasis-Associated in Colon Cancer-1 and the Risk of Breast Cancer Among the Chinese Han Population: A STROBE-Compliant Observational Study.
    Dai ZJ, Liu XH, Kang HF, Wang XJ, Jin TB, Zhang SQ, Feng T, Ma XB, Wang M, Feng YJ, Liu K, Xu P, Guan HT.
    Medicine (Baltimore); 2016 Feb 17; 95(6):e2801. PubMed ID: 26871844
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognosis of metastatic breast cancer subtypes: the hormone receptor/HER2-positive subtype is associated with the most favorable outcome.
    Lobbezoo DJ, van Kampen RJ, Voogd AC, Dercksen MW, van den Berkmortel F, Smilde TJ, van de Wouw AJ, Peters FP, van Riel JM, Peters NA, de Boer M, Borm GF, Tjan-Heijnen VC.
    Breast Cancer Res Treat; 2013 Oct 17; 141(3):507-14. PubMed ID: 24104881
    [Abstract] [Full Text] [Related]

  • 8. Prognostic impact of VEGFA germline polymorphisms in patients with HER2-positive primary breast cancer.
    Maae E, Andersen RF, Steffensen KD, Jakobsen EH, Brandslund I, Sørensen FB, Jakobsen A.
    Anticancer Res; 2012 Sep 17; 32(9):3619-27. PubMed ID: 22993299
    [Abstract] [Full Text] [Related]

  • 9. A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer.
    Absenger G, Szkandera J, Stotz M, Pichler M, Winder T, Langsenlehner T, Langsenlehner U, Samonigg H, Renner W, Gerger A.
    Mol Carcinog; 2013 Nov 17; 52 Suppl 1():E96-102. PubMed ID: 23625573
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in Klatskin tumor patients.
    Lederer A, Herrmann P, Seehofer D, Dietel M, Pratschke J, Schlag P, Stein U.
    Hepatology; 2015 Sep 17; 62(3):841-50. PubMed ID: 25953673
    [Abstract] [Full Text] [Related]

  • 12. Differential role of MACC1 expression and its regulation of the HGF/c‑Met pathway between breast and colorectal cancer.
    Sueta A, Yamamoto Y, Yamamoto-Ibusuki M, Hayashi M, Takeshita T, Yamamoto S, Omoto Y, Iwase H.
    Int J Oncol; 2015 May 17; 46(5):2143-53. PubMed ID: 25738887
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM, Ropponen KM, Kataja VV, Kellokoski JK, Eskelinen MJ, Kosma VM.
    Clin Cancer Res; 2004 Nov 15; 10(22):7621-8. PubMed ID: 15569994
    [Abstract] [Full Text] [Related]

  • 18. Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.
    Razis E, Kalogeras KT, Kotoula V, Eleftheraki AG, Nikitas N, Kronenwett R, Timotheadou E, Christodoulou C, Pectasides D, Gogas H, Wirtz RM, Makatsoris T, Bafaloukos D, Aravantinos G, Televantou D, Pavlidis N, Fountzilas G.
    Clin Breast Cancer; 2012 Jun 15; 12(3):183-93. PubMed ID: 22607768
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The impact of renin-angiotensin system, angiotensin І converting enzyme (insertion/deletion), and angiotensin ІІ type 1 receptor (A1166C) polymorphisms on breast cancer survival in Iran.
    Namazi S, Daneshian A, Mohammadianpanah M, Jafari P, Ardeshir-Rouhani-Fard S, Nasirabadi S.
    Gene; 2013 Dec 10; 532(1):125-31. PubMed ID: 24055489
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.